Alerta De Seguridad para HbA1c Kit - Registration no. 80115310145 - Models: R1: 2 x 15 ml + R2: 1 x 10 ml + R3: 1 x 5 ml - All lots manufactured in Brazil.

Según Agência Nacional de Vigilância Sanitária (ANVISA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Brazil que fue producido por KOVALENT DO BRASIL LTDA.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
    1134
  • Fecha
    2012-05-16
  • País del evento
  • Fuente del evento
    ANVISA
  • URL de la fuente del evento
  • Notas / Alertas
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notas adicionales en la data
    DiaSys Diagnostics Systems GmbH, Germany, forwarded the communiqué to Kovalent do Brasil Ltda., Which repacks, labels and markets the One HbA1c FS product in Brazil, stating that one of its customers observed a falsely high HbA1c value of 10, 4%, in a sample analyzed with the DiaSys brand HbA1c IS reagent (photometric analysis). As this value was unlikely, the same sample was evaluated by the HPLC method, giving a value equal to 7.5%. The investigations, to find the cause of the falsely elevated value of HbA1c when tested by photometry, resulted in the diagnosis of Severe Monoclonal Gamopathy of the patient. Gammatids are known to cause nonspecific turbidity in patient samples due to protein precipitation, and therefore interfere with photometric analysis. These are very rare cases and can not be avoided most of the time. There are no reports in the Notivisa system. Anvisa follows this action.
  • Causa
    Possibility of falsely elevated hba1c results when samples from patients with gammopathies are dosed by photometric analysis.
  • Acción
    The company has already promoted the communication to its customers and made the change in the product label, emphasizing the falsification condition by samples from patients with gamma. See attached.

Manufacturer